How We WorkOrder NowSupport Privacy

Traders Watch List – Sequenom, Inc. (NASDAQ:SQNM), Peregrine Pharmaceuticals (NASDAQ:PPHM)

on 18/03/2013

Massapequa Park – March 18 , 2013 — (Net PR News) -King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today, we bring a special trend analysis of the following stocks:

PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy

Biotechnology industry of the Healthcare Sector is in the news. Sequenom, Inc. (NASDAQ:SQNM) remained a high volume stock in its industry and was showing bearish movement during prior trade and Dollar General Corp. (NYSE:DG) gained attention of investors and both stocks were showing superb trends during previous trade.

Sequenom, Inc. (NASDAQ:SQNM) revealed that, at the Ritz-Carlton Hotel, on Monday, March 18, 2013, starting at 12:30 p.m. PT, the President and Chief Operating Officer of the company, William Welch, M.B.A, will present at the 25th Annual Roth Conference in Laguna Niguel, CA.

Is SQNM a Solid Investment at These Levels? Read This Report For Details

 Biotechnology company showing negative movement during previous trade, Sequenom, Inc. (NASDAQ:SQNM) remained among the day losers and traded with volume of 2.66 million shares in the last trading session, as compared to average volume of 3.31 million shares.

SQNM has total market capitalization of $519.98 million with a total of 114.79 million outstanding shares. The stock on Friday decreased -1.52% and finished the day at $4.53. SQNM was a gainer in the 5 days activities and jumped about 5.1%. The 52 week range of the stock remained $2.65 – $5.83. The one month performance of the stock was positive and it scored more than +3%.

Peregrine Pharmaceuticals (NASDAQ:PPHM) unveiled its financial results for the 3rd quarter and fiscal year of 2013 and also provided an update about its business developments.

The total revenues of PPHM remained $7,039,000 for the 3rd quarter of fiscal year 2013, versus the 3rd quarter of a year ago total revenue of $3,281,000.

How Should Investors Trade PPHM Now? Don’t Miss out a Special Trend Analysis

Peregrine Pharmaceuticals was moving downward during the previous trading session. Peregrine Pharmaceuticals (NASDAQ:PPHM) traded with a plunge of -2.13% and closed at $1.38 after gaining total volume of 2.46 million shares. Its opening price was $1.44.

If we look at the previous six month’s performance of the stock, it remained pessimistic with the loss of -65.15%. In its last one month’s trade it surged -25%. Peregrine Pharmaceuticals’ earnings per share is $-0.39, while its beta value stands at 0.90 times. PPHM has total market capitalization of $182.90 million with a total of 132.54 million outstanding shares.

About Us:

King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.

King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.

Disclaimer:

Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.

An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.

Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/

 

Source: kingPennyStocks.com Posted Mon, March 18, 2013 14:44 - Permalink